Almitas Capital LLC Amylyx Pharmaceuticals, Inc. Transaction History
Almitas Capital LLC
- $177 Million
- Q1 2025
A detailed history of Almitas Capital LLC transactions in Amylyx Pharmaceuticals, Inc. stock. As of the latest transaction made, Almitas Capital LLC holds 2,122,597 shares of AMLX stock, worth $17.4 Million. This represents 4.25% of its overall portfolio holdings.
Number of Shares
2,122,597
Previous 2,032,370
4.44%
Holding current value
$17.4 Million
Previous $7.66 Million
1.94%
% of portfolio
4.25%
Previous 3.73%
Shares
4 transactions
Others Institutions Holding AMLX
# of Institutions
150Shares Held
74.5MCall Options Held
148KPut Options Held
98.7K-
Perceptive Advisors LLC New York, NY7.87MShares$64.6 Million1.17% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA5.94MShares$48.8 Million5.07% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.7MShares$46.8 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.5MShares$36.9 Million0.0% of portfolio
-
Saturn V Capital Management LLC Austin, TX3.26MShares$26.8 Million8.47% of portfolio
About Amylyx Pharmaceuticals, Inc.
- Ticker AMLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,533,200
- Market Cap $481M
- Description
- Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...